公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2024 | Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases | Cheng, Pin-Nan; WEN-JONE CHEN ; Hou, Charles Jia-Yin; Lin, Chih-Lin; Chang, Ming-Ling; Wang, Chia-Chi; Chang, Wei-Ting; Wang, Chao-Yung; Lin, Chun-Yen; Hung, Chung-Lieh; Peng, Cheng-Yuan; Yu, Ming-Lung; Chao, Ting-Hsing; Huang, Jee-Fu; Huang, Yi-Hsiang; Chen, Chi-Yi; Chiang, Chern-En; Lin, Han-Chieh; Li, Yi-Heng; TSUNG-HSIEN LIN ; JIA-HORNG KAO ; TZUNG-DAU WANG ; Liu, Ping-Yen; YEN-WEN WU ; CHUN-JEN LIU | Clinical and molecular hepatology | 1 | | |
2019 | Taiwan consensus statement on the management of chronic hepatitis B | Chien R.-N.; JIA-HORNG KAO ; Peng C.-Y.; Chen C.-H.; CHUN-JEN LIU ; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; YEN-HSUAN NI ; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN ; Liaw Y.-F. | Journal of the Formosan Medical Association | 56 | 47 | |
1993 | Taiwanese patient with recurrent polyserositis: report of a case | Lee, W Y; Tsai, S; JIA-HORNG KAO ; Lai, M Y | Journal of the Formosan Medical Association = Taiwan yi zhi | | | |
2017 | Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma | Hu M.-H.; Chen L.-J.; Chen Y.-L.; Tsai M.-S.; Shiau C.-W.; Chao T.-I.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F. | Oncotarget | 17 | 15 | |
2023 | TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes | Yu, Ming-Lung; CHIH-YUAN WANG ; Lee, Mei-Hsuan; Ou, Horng-Yih; Cheng, Pin-Nan; Tu, Shih-Te; Huang, Jee-Fu; Chen, Jung-Fu; Hu, Tsung-Hui; Hsu, Chih-Cheng; JIA-HORNG KAO ; Chen, Chien-Jen; Lin, Han-Chieh; Huang, Chien-Ning | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 2 | |
2009 | Telaprevir for chronic HCV infection | JIA-HORNG KAO | New England Journal of Medicine | 3 | 3 | |
2017 | Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model | JIA-HORNG KAO ; Asselah T.; Dou X.-G.; Hamed K. | Journal of Gastroenterology and Hepatology (Australia) | 5 | 6 | |
2023 | Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B | Lim, Young-Suk; Chan, Henry L Y; Ahn, Sang Hoon; Seto, Wai Kay; Ning, Qin; Agarwal, Kosh; Janssen, Harry L A; Pan, Calvin Q; Chuang, Wan Long; Izumi, Namiki; Fung, Scott; Shalimar, null; Brunetto, Maurizia; Hui, Aric Josun; Chang, Ting-Tsung; Lim, Seng Gee; Abramov, Frida; Flaherty, John F; Wang, Hongyuan; Yee, Leland J; JIA-HORNG KAO ; Gane, Edward; Hou, Jinlin; Buti, Maria | JHEP reports : innovation in hepatology | 1 | 0 | |
2024 | Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy | Chang, Kai-Chun; TUNG-HUNG SU ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHANG-CHIN HUANG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | | | |
1991 | Therapeutic effect of ursodeoxycholic acid on early-stage primary biliary cirrhosis | JIA-HORNG KAO ; Lai M.Y.; Lin J.W.; PEI-MING YANG ; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Sung J.L.; Wang T.H. | Journal of the Formosan Medical Association | 4 | 0 | |
2005 | Therapeutic implications of hepatitis B virus genotypes | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 109 | 82 | |
2021 | Three heads are better than two: Hepatitis b core-related antigen as a new predictor of hepatitis b virus-related hepatocellular carcinoma | Wu J.-W.; JIA-HORNG KAO ; TAI-CHUNG TSENG | Clinical and Molecular Hepatology | 19 | 18 | |
2017 | Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy | Chien N.-H.; Huang Y.-T.; Wu C.-Y.; Chang C.-Y.; MING-SHIANG WU ; JIA-HORNG KAO ; Mo L.-R.; Tai C.-M.; Lin C.-W.; Yang T.-H.; Lin J.-T.; Hsu Y.-C. | BMC Gastroenterology | 8 | 5 | |
2007 | To genotype or not to genotype: Toward an optimal tailoring of treatment of chronic hepatitis B [3] | Lin C.-.; JIA-HORNG KAO | Clinical Infectious Diseases | 2 | 3 | |
2023 | Toward the hepatitis C virus elimination in Asia: The policy forum from the 2023 Asian Pacific Association of the Study of the Liver (APASL) | CHEN-HUA LIU ; Lin, Han-Chieh; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
2015 | Towards an HBV cure: State-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure | Zeisel M.B.; Lucifora J.; Mason W.S.; Sureau C.; Beck J.; Levrero M.; Kann M.; Knolle P.A.; Benkirane M.; Durantel D.; Michel M.-L.; Autran B.; Cosset F.-L.; Strick-Marchand H.; Trépo C.; JIA-HORNG KAO ; Carrat F.; Lacombe K.; Schinazi R.F.; Barré-Sinoussi F.; Delfraissy J.-F.; Zoulim F. | Gut | 225 | 202 | |
2020 | Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943-2020) | HUNG-CHIH YANG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 3 | 2 | |
2011 | Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients | CHEN-HUA LIU ; Liang, Cheng-Chao; KAI-WEN HUANG ; CHUN-JEN LIU ; Chen, Shih-I; JOU-WEI LIN ; Hung, Peir-Haur; Tsai, Hung-Bin; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical journal of the American Society of Nephrology : CJASN | 71 | 69 | |
1992 | Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: Putative serological marker for acute viral infection | PEI-JER CHEN ; JIN-TOWN WANG ; Hwang L.-H.; Yang Y.-H.; Hsieh C.-L.; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 61 | 59 | |
2021 | Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients | Liu M.; TAI-CHUNG TSENG ; Jun D.W.; Yeh M.-L.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung M.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO ; Yang H.-I.; Nguyen M.H. | Hepatology International | 15 | 14 | |